Auren Rx Review (2026): $199 Semaglutide, No Commitment

Auren Rx (aurenrx.com) publishes two prices for every product it sells: a discounted subscription rate, and an explicit "monthly — no commitment" rate beside it. For semaglutide those are $169 and $199; for its separate microdose program, $129 and $149.¹ The no-commitment rung is the one we file, because it is the one you can actually leave.

That structure is rarer than it sounds. Most sellers offer a subscription and a prepay plan and let you infer that the subscription is the flexible one. Auren Rx spells out what flexibility costs — $30 a month on standard semaglutide, $20 on the microdose — and lets you decide. We checked it in August 2026.

The semaglutide rungs

Standard semaglutide is $169 a month subscribed, $199 month to month. Microdose semaglutide is $129 subscribed, $149 month to month. Tirzepatide, if that is the comparison you are making, is $259 / $299 standard and $229 / $250 microdose.¹

Billing runs approximately every 28 to 30 days, which the site discloses in plain language rather than printing "monthly" and hoping nobody counts. Terms describe a month-to-month membership cancellable at any time, and there is no prepay tier at all — which removes the most common way a cost comparison gets poisoned. Where $199 sits against everyone else is on our price-ordered semaglutide board.

Two ways to read this page wrong

Both of these are live on the site, and both produce a wrong number rather than a missing one.

The selector defaults to tirzepatide. The weight-loss page loads with the second variant selected, not the first. If you open it, glance at the price and close the tab, the figure you carry away is $299 or $259 — tirzepatide's — filed in your head under "semaglutide". Click the molecule you actually want before reading anything.

The site's own structured data reports the cheaper rung. Its product markup emits the subscribe price, $169 for semaglutide, as the offer price. Anything that reads structured data rather than the page — an aggregator, a shopping panel, an answer engine — will report $169 as Auren Rx's semaglutide price. The no-commitment rate is $199, and that is the one to budget against unless you intend to lock in.

There is a third, smaller version of the same problem in the navigation, which advertises "Semaglutide and Tirzepatide from $129/mo". $129 is the microdose subscribe rung. The cheapest standard GLP-1 rung is $169 subscribed or $199 monthly — so a header figure sitting under a GLP-1 heading understates standard semaglutide by $70 a month. Nothing there is fabricated; it is just the cheapest thing in the category, labelled as the category.

The microdose program is a real program

Auren Rx runs microdosing as a separate product with its own page, its own intake and its own four-rung price table across both molecules — not as a footnote on the weight-loss page. At $129 subscribed or $149 month to month for semaglutide, it is one of the lower GLP-1 rungs we have verified.

Microdosing is not the labelled use of the drug, and the trial evidence behind semaglutide's weight-loss results was generated at 2.4 mg, not below it. If you are considering it, read how long people actually stay on semaglutide and the standard dose ladder first, so you know what you are opting out of.

What it will not tell you

Auren Rx never publishes the states it serves. Its terms say services are available to individuals "located in certain states" and "a State Where We Operate", and the states are named nowhere on the site. Every other provider in this batch discloses this, several of them precisely. It is the single biggest gap in an otherwise strong disclosure record, and it means you cannot rule yourself in or out before starting an intake.

The pharmacy is not named individually either — dispensing is attributed to "the Auren RX Pharmacy Network", though you may elect a local pharmacy of your own, in which case the membership fee excludes the medication. Clinical work runs through Beluga Health, P.A., a real and established telehealth professional association, but no individual prescriber is named and no NPI is published, so nothing can be checked against the national registry. The legal entity is Hades Capital LLC, doing business as Auren RX, with no address published.

The membership fee is charged the day membership starts and is non-refundable once paid. Membership begins after a provider has communicated a care plan and you elect to proceed, so it follows clinical review rather than preceding it — better than the sellers that bill at intake — but a non-refundable first charge is still a first charge.

Product-page star ratings appear with no review count and no source. We have not repeated them.

The rest of the catalogue

NAD+ is unusually granular for this market: seven rungs across injection, nasal spray and cream, $155 to $249 a month, with strength and volume stated for each. Sermorelin is $199 a month, glutathione $119 injectable or $109 nasal, GHK-Cu cream $109. There is no research-chemical line — no retatrutide, no melanotan, no testosterone. All month-to-month figures.¹

The regulatory screen

The trading name, the legal entity, the medical group and the intake platform all returned zero company-column matches in the FDA's live warning-letter index in August 2026, in a pass whose control query correctly returned a known February 2026 letter for an unrelated seller.² Clean.

Where it lands

If what you want is to try compounded semaglutide without committing to anything, Auren Rx is the clearest option in this batch: $199, cancel whenever, no prepay tier to muddle the comparison, and the discount for committing stated as a number rather than implied. If you need to know whether it operates in your state before you hand over an intake, it will not tell you, and that is a real cost.

Weigh it against Trellis Vitality's published 1/3/6 table, The Edit's $209, and the rest of the programs we track.